Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Chen LM, Cristea M, DeRosa M, Eisenhauer EL, Gershenson DM, Gray HJ, Grisham R, Hakam A, Jain A, Karam A, Konecny GE, Leath CA, Liu J, Mahdi H, Martin L, Matei D, McHale M, McLean K, Miller DS, O'Malley DM, Percac-Lima S, Ratner E, Remmenga SW, Vargas R, Werner TL, Zsiros E, Burns JL, Engh AM.
J Natl Compr Canc Netw. 2021 Feb 2;19(2):191-226. doi: 10.6004/jnccn.2021.0007.
PMID:33545690
Intracystic endometrioid borderline tumor.
El Hajj H, Narducci F, McCluggage G, Pasquesoone C.
Int J Gynecol Cancer. 2023 Oct 2;33(10):1663-1665. doi: 10.1136/ijgc-2022-004151.
PMID:37543373
Ovarian cancer: epidemiology and risk factors.
La Vecchia C.
Eur J Cancer Prev. 2017 Jan;26(1):55-62. doi: 10.1097/CEJ.0000000000000217.
PMID:26731563
Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
Ricotta G, Maulard A, Genestie C, Pautier P, Leary A, Chargari C, Candiani M, Morice P, Gouy S.
Ann Surg Oncol. 2021 Oct;28(11):6714-6720. doi: 10.1245/s10434-021-09879-y. Epub 2021 Mar 25.
PMID:33768396
A rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component.
Hammouda SB, Njima M.
Pan Afr Med J. 2022 Jan 26;41:73. doi: 10.11604/pamj.2022.41.73.30418. eCollection 2022.
PMID:35382040
Comparative study of endometrioid borderline ovarian tumor with and without endometriosis.
Zhang W, Jia S, Xiang Y, Yang J, Jia C, Leng J.
J Ovarian Res. 2018 Aug 11;11(1):67. doi: 10.1186/s13048-018-0440-x.